Episode
How Drug Price Negotiation Is Reshaping Clinical Trial Pipelines
- Podcast
- A Health Podyssey
- Published
- Feb 24, 2026
- Duration seconds
- 1232
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/13d8613e
Actions
POST https://stenobird.com/v1/public/podcasts/a-health-podyssey-1366621/episodes/how-drug-price-negotiation-is-reshaping-clinical-trial-pipelines/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/a-health-podyssey-1366621/how-drug-price-negotiation-is-reshaping-clinical-trial-pipelines.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Health Affairs ' Rob Lott interviews So-Yeon Kang of Georgetown University about her recent paper exploring trends in biopharmaceutical clinical trials after The Inflation Reduction Act of 2022 authorized Medicare to negotiate prices for selected drugs. Order the January 2026 issue of Health Affairs . Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support , we can continue to keep our digital publication Forefront and podcast for everyone.